The future of precision neurology isn't just finding variants. It's determining what they do.
This study is a proof-of-concept for the Holmes Lab VUS initiative: connecting patient genetics with biology to functionally interpret rare variants and uncover disease mechanisms.
This study is a proof-of-concept for the Holmes Lab VUS initiative: connecting patient genetics with biology to functionally interpret rare variants and uncover disease mechanisms.